{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:26:01Z","timestamp":1761974761231},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,10,9]],"date-time":"2008-10-09T00:00:00Z","timestamp":1223510400000},"content-version":"vor","delay-in-days":2838,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2001,1]]},"abstract":"<jats:p> <jats:bold>Background <\/jats:bold> Based on the involvement of cytokines and growth factors in bone homeostasis, we hypothesised that patients with common variable immunodeficiency (CVI), characterised by persistent immune activation <jats:italic>in vivo<\/jats:italic>, may have disturbed bone metabolism as evaluated by biochemical markers of bone turnover.<\/jats:p><jats:p> <jats:bold>Materials and methods <\/jats:bold> Serum levels of tumour necrosis factor \u03b1 (TNF\u03b1), interleukin\u20106 (IL\u20106), bone\u2010specific alkaline phosphatase (B\u2010ALP), osteocalcin, carboxyterminal crosslinking telopeptide of type I collagen (CTX\u2010I), insulin\u2010like growth factor (IGF)\u2010I and IGF binding protein\u20103 (IGFBP\u20103) were measured in 25 patients with CVI and compared to 25 age\u2010 and sex\u2010matched healthy controls.<\/jats:p><jats:p> <jats:bold>Results<\/jats:bold> Patients with CVI had significantly higher serum levels of CTX\u2010I and B\u2010ALP, and significantly lower serum levels of IGF\u2010I and IGFBP\u20103 compared to controls as shown in cross\u2010sectional, and as for B\u2010ALP and CTX\u2010I, also during longitudinal testing. No differences were observed for osteocalcin between the two groups. The elevated B\u2010ALP and decreased IGF\u2010I and IGFBP\u20103 levels were most pronounced in a subgroup of CVI patients characterised by persistent activation of proinflammatory cytokines <jats:italic>in vivo<\/jats:italic>. Raised B\u2010ALP and decreased IGF\u2010I and IGFBP\u20103 were also significantly correlated with enhanced IL\u20106 and TNF\u2010\u03b1 levels in these patients.<\/jats:p><jats:p> <jats:bold>Conclusions<\/jats:bold> The present study suggests that persistent immune activation <jats:italic>in vivo<\/jats:italic>, with raised levels of proinflammatory cytokines, may be related to disturbed bone homeostasis in CVI patients, further supporting an interaction between immune related mediators and bone metabolism in humans.<\/jats:p>","DOI":"10.1046\/j.1365-2362.2001.00768.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T15:50:42Z","timestamp":1047397842000},"page":"72-78","source":"Crossref","is-referenced-by-count":11,"title":["Increased levels of biochemical markers of bone turnover in relation to persistent immune activation in common variable immunodeficiency"],"prefix":"10.1111","volume":"31","author":[{"given":"T.","family":"Ueland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S S.","family":"Fr\u00f8land","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bollerslev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,9]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650100217"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1210\/endo.139.7.6085","article-title":"Prostaglandin E2, interleukin 1\u2010alpha, and tumor necrosis factor\u2010alpha increase human osteoclast formation and bone resorption in vitro","volume":"139","author":"Lader CS","year":"1998","journal-title":"Endocrinology"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/s8756-3282(00)00263-5"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-6009(08)80117-1"},{"key":"e_1_2_6_6_2","first-page":"15","article-title":"Interleukin\u20101 beta stimulates bone resorption and inhibits bone formation in vivo","volume":"10","author":"Nguyen L","year":"1991","journal-title":"Lymphokine Cytokine Res"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01534268"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1998.13.8.1290"},{"issue":"1","key":"e_1_2_6_9_2","first-page":"1","article-title":"Primary immunodeficiency diseases","volume":"99","author":"WHO Scientific Group Report.","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90882-P"},{"key":"e_1_2_6_11_2","first-page":"199","article-title":"Cellular abnormalities in common variable immunodeficiency","volume":"2","author":"Spickett GP","year":"1990","journal-title":"Immunodefic Rev"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4049\/jimmunol.162.2.1178","article-title":"Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency","volume":"162","author":"Aukrust P","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1994.1032"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1991.tb05805.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00757.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V87.2.674.bloodjournal872674","article-title":"Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency \u2013 possible immunologic and clinical consequences","volume":"87","author":"Aukrust P","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1992.tb06934.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1997.12.7.1028"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1210\/jcem.83.11.5270","article-title":"Severe deficiency of 1,25\u2010dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis","volume":"83","author":"Haug CJ","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2000.00619.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0083-6729(08)60407-0"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(95)00135-z"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01673412"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.1.145"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.27.19301"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.7.3597"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.0252"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-118-4-1340"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(92)90189-H"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(96)00254-2"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118432"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.9.5364"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.15.8958"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb09563.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113318"},{"key":"e_1_2_6_36_2","first-page":"1","article-title":"Autocrine and paracrine aspects of bone metabolism","volume":"6","author":"Mohan S","year":"1990","journal-title":"Growth Gen Horm"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.3.669"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-206-43726"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.16.1.3"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1350729"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.2001.00768.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.2001.00768.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2362.2001.00768.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T16:33:37Z","timestamp":1697560417000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2362.2001.00768.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1046\/j.1365-2362.2001.00768.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2362.2001.00768.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}